\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ significant\\ findings\\.\ \(1\)\
\-\ continued\\ on\\ glucocorticoid\\ therapy\\ and\\ testosterone\\ for\\ his\\ associated\\ hypogonadism\\.\ \(0\)\
\-\ ultrasound\\ of\\ the\\ left\\ testis\\ demonstrates\\ a\\ lobulated\\,\\ hyperechoic\\ mass\\.\ \(0\)\
\-\ adrenal\\ rest\\ tumor\ \(3\)\
\-\ testicular\\ neoplasm\ \(15\)\
\-\ germ\\ cell\\ tumors\ \(18\)\
\-\ \\ \\-\\ seminoma\ \(1\)\
\-\ \\ \\-\\ embryonal\\ cell\ \(1\)\
\-\ \\ \\-\\ teratoma\ \(2\)\
\-\ \\ \\-\\ choriocarcinoma\ \(1\)\
\-\ \\ \\-\\ yolk\\ sac\ \(1\)\
\-\ \\ \\-\\ mixed\\ germ\\ cell\ \(1\)\
\-\ stromal\\ tumors\ \(3\)\
\-\ \\ \\-\\ leydig\\ cell\\ tumor\ \(0\)\
\-\ \\ \\-\\ sertoli\\ cell\\ tumor\ \(0\)\
\-\ lymphoma\\/leukemia\ \(2\)\
\-\ metastases\ \(207\)\
\-\ epidermoid\\ cyst\ \(38\)\
\-\ non\\-neoplastic\\ lesions\ \(0\)\
\-\ focal\\ orchitis\ \(3\)\
\-\ abscess\ \(594\)\
\-\ hematoma\ \(500\)\
\-\ sarcoid\ \(163\)\
\-\ tuberculosis\ \(73\)\
\-\ adrenal\\ rest\\ tissue\ \(2\)\
\-\ 44\\ year\\ old\\ male\\ with\\ addison\\'s\\ disease\\ on\\ glucocorticoid\\ and\\ testosterone\\ therapy\\ s\\/p\\ r\\ orchiectomy\\.\ \(0\)\
\-\ this\\ patient\\ had\\ typical\\ clinical\\ findings\\ of\\ addison\\'s\\ disease\\ prior\\ to\\ initiation\\ of\\ glucocorticoid\\ treatment\\ and\\ thus\\ had\\ elevated\\ levels\\ of\\ acth\\ to\\ stimulate\\ development\\ of\\ the\\ adrenal\\ rest\\ tumors\\.\\ \\ he\\ initially\\ underwent\\ right\\ orchiectomy\\ prior\\ to\\ his\\ diagnosis\\ because\\ the\\ lesions\\ were\\ intially\\ believed\\ to\\ be\\ lymphoma\\.\\ \\ classically\\,\\ adrenal\\ rest\\ tumors\\ appear\\ as\\ multiple\\ round\\,\\ hypoechoic\\ nodules\\ near\\ the\\ hilus\\ and\\ are\\ usually\\ bilateral\\.\\ \\ however\\ with\\ this\\ patient\\,\\ his\\ residual\\ adrenal\\ rest\\ tissue\\ appears\\ hyperechoic\\ on\\ ultrasound\\.\\ \\ this\\ is\\ believed\\ to\\ be\\ secondary\\ to\\ the\\ tissue\\ undergoing\\ extensive\\ fibrosis\\,\\ and\\ it\\ may\\ be\\ associated\\ with\\ acoustic\\ shadowing\\.\\ \\ this\\ patient\\'s\\ adrenal\\ rest\\ tumor\\ did\\ not\\ show\\ significant\\ change\\ despite\\ glucocorticoid\\ therapy\\.\\ \\ serial\\ sonography\\ is\\ recommended\\ to\\ document\\ stability\\ and\\ regression\\ in\\ tumor\\ size\\ during\\ therapy\\,\\ and\\ because\\ there\\ is\\ a\\ very\\ rare\\ chance\\ of\\ malignant\\ degeneration\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.34970698639181175\ \(0\)\
\-\ glucocorticoid\\:\\ 0\\.34728674561218614\ \(0\)\
\-\ rest\\:\\ 0\\.3265257114746543\ \(0\)\
\-\ addison\\:\\ 0\\.2012851406694537\ \(0\)\
\-\ tumors\\:\\ 0\\.185134092699672\ \(0\)\
\-\ cell\\:\\ 0\\.18000109384486718\ \(0\)\
\-\ tumor\\:\\ 0\\.1645864208966839\ \(0\)\
\-\ testosterone\\:\\ 0\\.16367048233727322\ \(0\)\
\-\ therapy\\:\\ 0\\.14463492745365086\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.14385772150505752\ \(0\)\
\-\ believed\\:\\ 0\\.13464054336642556\ \(0\)\
\-\ germ\\:\\ 0\\.11753902609440382\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.11586847176484553\ \(0\)\
\-\ his\\:\\ 0\\.11450090767285043\ \(0\)\
\-\ to\\:\\ 0\\.11013079343112808\ \(0\)\
\-\ tissue\\:\\ 0\\.09903871860031749\ \(0\)\
\-\ intially\\:\\ 0\\.09616934887269744\ \(0\)\
\-\ and\\:\\ 0\\.09102943578144576\ \(0\)\
\-\ hypogonadism\\:\\ 0\\.09053375632011948\ \(0\)\
\-\ hilus\\:\\ 0\\.09053375632011948\ \(0\)\
\-\ because\\:\\ 0\\.08796558081651684\ \(0\)\
\-\ this\\:\\ 0\\.08649879144675715\ \(0\)\
\-\ stimulate\\:\\ 0\\.08288673372206455\ \(0\)\
\-\ initiation\\:\\ 0\\.08183524116863661\ \(0\)\
\-\ acth\\:\\ 0\\.08183524116863661\ \(0\)\
\-\ leydig\\:\\ 0\\.08087530367658757\ \(0\)\
\-\ sertoli\\:\\ 0\\.07999224678541682\ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.07841351226003514\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0776357157844856\ \(0\)\
\-\ document\\:\\ 0\\.07703267221703061\ \(0\)\
\-\ be\\:\\ 0\\.07658744765836696\ \(0\)\
\-\ orchitis\\:\\ 0\\.07580559524257938\ \(0\)\
\-\ lymphoma\\:\\ 0\\.07496025388630281\ \(0\)\
\-\ of\\:\\ 0\\.07389352509598669\ \(0\)\
\-\ embryonal\\:\\ 0\\.07369781243111222\ \(0\)\
\-\ significant\\:\\ 0\\.07267153562040697\ \(0\)\
\-\ yolk\\:\\ 0\\.07234522418736188\ \(0\)\
\-\ chance\\:\\ 0\\.07234522418736188\ \(0\)\
\-\ lesions\\:\\ 0\\.07228555534359352\ \(0\)\
\-\ regression\\:\\ 0\\.07152764120693667\ \(0\)\
\-\ prior\\:\\ 0\\.07042155034851345\ \(0\)\
\-\ seminoma\\:\\ 0\\.06906584979038423\ \(0\)\
\-\ testis\\:\\ 0\\.06815857264452443\ \(0\)\
\-\ sonography\\:\\ 0\\.06679482373054582\ \(0\)\
\-\ associated\\:\\ 0\\.06634016331831134\ \(0\)\
\-\ classically\\:\\ 0\\.06581352646109886\ \(0\)\
\-\ stability\\:\\ 0\\.0634934798840649\ \(0\)\
\-\ acoustic\\:\\ 0\\.06311946706392525\ \(0\)\
\-\ the\\:\\ 0\\.06278644716123238\ \(0\)\
\-\ had\\:\\ 0\\.0627104475820154\ \(0\)\
\-\ findings\\:\\ 0\\.062119304002023853\ \(0\)\
\-\ patient\\:\\ 0\\.06140622833067848\ \(0\)\
\-\ shadowing\\:\\ 0\\.06065767564737282\ \(0\)\
\-\ testicular\\:\\ 0\\.059020258422035496\ \(0\)\
\-\ degeneration\\:\\ 0\\.05852434025568156\ \(0\)\
\-\ lobulated\\:\\ 0\\.05804975862991706\ \(0\)\
\-\ serial\\:\\ 0\\.05793423588242277\ \(0\)\
\-\ thus\\:\\ 0\\.05781991028338384\ \(0\)\
\-\ residual\\:\\ 0\\.05726540555889132\ \(0\)\
\-\ undergoing\\:\\ 0\\.05715777229950547\ \(0\)\
\-\ on\\:\\ 0\\.0570199736991834\ \(0\)\
\-\ sac\\:\\ 0\\.05603832858444009\ \(0\)\
\-\ 44\\:\\ 0\\.05565786599996605\ \(0\)\
\-\ despite\\:\\ 0\\.05476043474639724\ \(0\)\
\-\ teratoma\\:\\ 0\\.05442095191244239\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.05377180459427435\ \(0\)\
\-\ disease\\:\\ 0\\.052833551873365366\ \(0\)\
\-\ fibrosis\\:\\ 0\\.052720312040846415\ \(0\)\
\-\ mixed\\:\\ 0\\.052093702670414195\ \(0\)\
\-\ development\\:\\ 0\\.0520262264871029\ \(0\)\
\-\ is\\:\\ 0\\.0517033765476237\ \(0\)\
\-\ continued\\:\\ 0\\.051565107122410685\ \(0\)\
\-\ round\\:\\ 0\\.051565107122410685\ \(0\)\
\-\ near\\:\\ 0\\.05124715077641686\ \(0\)\
\-\ recommended\\:\\ 0\\.0500597346772014\ \(0\)\
\-\ nodules\\:\\ 0\\.05000359042585314\ \(0\)\
\-\ levels\\:\\ 0\\.04989215188662179\ \(0\)\
\-\ appear\\:\\ 0\\.049564435070550465\ \(0\)\
\-\ initially\\:\\ 0\\.049351243478434184\ \(0\)\
\-\ typical\\:\\ 0\\.048635935112926715\ \(0\)\
\-\ extensive\\:\\ 0\\.04848850768635904\ \(0\)\
\-\ change\\:\\ 0\\.04768837263236007\ \(0\)\
\-\ rare\\:\\ 0\\.0475082490952144\ \(0\)\
\-\ appears\\:\\ 0\\.0460854510398395\ \(0\)\
\-\ did\\:\\ 0\\.04514516149880697\ \(0\)\
\-\ very\\:\\ 0\\.04514516149880697\ \(0\)\
\-\ malignant\\:\\ 0\\.044860440623712146\ \(0\)\
\-\ underwent\\:\\ 0\\.04335220040578598\ \(0\)\
\-\ neoplasm\\:\\ 0\\.04296083554738758\ \(0\)\
\-\ elevated\\:\\ 0\\.04290183903471052\ \(0\)\
\-\ size\\:\\ 0\\.04261149802623904\ \(0\)\
\-\ show\\:\\ 0\\.03995092066259403\ \(0\)\
\-\ clinical\\:\\ 0\\.03988358176636865\ \(0\)\
\-\ during\\:\\ 0\\.039861226497159466\ \(0\)\
\-\ usually\\:\\ 0\\.03961826264888764\ \(0\)\
\-\ secondary\\:\\ 0\\.03730160651746666\ \(0\)\
\-\ he\\:\\ 0\\.03726624648213256\ \(0\)\
\-\ however\\:\\ 0\\.03724860887393179\ \(0\)\
\-\ with\\:\\ 0\\.03696883822981185\ \(0\)\
\-\ cyst\\:\\ 0\\.036303367429852844\ \(0\)\
\-\ bilateral\\:\\ 0\\.033822181361520036\ \(0\)\
\-\ diagnosis\\:\\ 0\\.032623697893130535\ \(0\)\
\-\ were\\:\\ 0\\.032439821610326616\ \(0\)\
\-\ it\\:\\ 0\\.032214203899104524\ \(0\)\
\-\ may\\:\\ 0\\.03166955620976735\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03161654158790556\ \(0\)\
\-\ multiple\\:\\ 0\\.030781594974626177\ \(0\)\
\-\ treatment\\:\\ 0\\.02997803019377418\ \(0\)\
\-\ male\\:\\ 0\\.02801991488861711\ \(0\)\
\-\ as\\:\\ 0\\.025282169107078704\ \(0\)\
\-\ there\\:\\ 0\\.02504059727394388\ \(0\)\
\-\ not\\:\\ 0\\.02484420521152986\ \(0\)\
\-\ mass\\:\\ 0\\.024038487803328366\ \(0\)\
\-\ are\\:\\ 0\\.023879974708889085\ \(0\)\
\-\ left\\:\\ 0\\.0214676061566956\ \(0\)\
\-\ right\\:\\ 0\\.02086468666730284\ \(0\)\
\-\ no\\:\\ 0\\.020464892725700453\ \(0\)\
\-\ year\\:\\ 0\\.019394519384052213\ \(0\)\
\-\ for\\:\\ 0\\.019074320311021842\ \(0\)\
\-\ old\\:\\ 0\\.018625452188182963\ \(0\)\
\-\ in\\:\\ 0\\.015655532841992684\ \(0\)\
